See Structure-Activity Relationship.
Glossary
SAR
02.27.12
-
Pharma Tech Industries Names Capuano COO
Hires new chief operating officerReleased by: Pharma Tech Industries
-
Breaking News | Drug Development | Industry News | Preclinical Outsourcing
Pierre Fabre Buys Igenica Immuno-oncology Assets
Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area
-
Lyophilization
-
Bioassay Development | Breaking News | Drug Development | Industry News | Methods Development | Process Development | Toxicology
Regeneron Acquires Sanofi Ophthalmology Programs
Deal worth as much as $50 million, plus royalties
-
Breaking News | Toxicology
Keller and Heckman Adds Former FDA Tox Expert
Twaroski will serve as a scientist in the Washington, DC office
